The use of extracorporeal membrane oxygenation in the treatment of critical course of pneumonia
Extracorporeal membrane oxygenation is the highest form of resuscitation care in management of patients with respiratory failure. In the case of acute respiratory distress syndrome, the veno-venous setting is more often used. ECMO support enables, in case of lung function failure, to obtain the necessary time for the onset of the causal treatment effect or is used as a bridge to transplantation Mortality of the patients varies according to the underlying cause and presence of risk factors (e.g., age, complications or comorbid diseases). The onset of the COVID-19 pandemic has led to a significant increase in the need for ECMO. The quality of life of patients after ECMO is significantly reduced, but most patients do not experience permanent disability.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:161 |
|---|---|
| Enthalten in: |
Casopis lekaru ceskych - 161(2023), 7-8 vom: 01., Seite 321-324 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Využití extrakorporální membránové oxygenace (ECMO) v léčbě kritického průběhu pneumonie |
|---|
| Beteiligte Personen: |
Genzor, Samuel [VerfasserIn] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 07.03.2023 Date Revised 07.03.2023 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM353747343 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353747343 | ||
| 003 | DE-627 | ||
| 005 | 20231226060727.0 | ||
| 007 | tu | ||
| 008 | 231226s2023 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1179.xml |
| 035 | |a (DE-627)NLM353747343 | ||
| 035 | |a (NLM)36868842 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Genzor, Samuel |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The use of extracorporeal membrane oxygenation in the treatment of critical course of pneumonia |
| 246 | 3 | 3 | |a Využití extrakorporální membránové oxygenace (ECMO) v léčbě kritického průběhu pneumonie |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 07.03.2023 | ||
| 500 | |a Date Revised 07.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Extracorporeal membrane oxygenation is the highest form of resuscitation care in management of patients with respiratory failure. In the case of acute respiratory distress syndrome, the veno-venous setting is more often used. ECMO support enables, in case of lung function failure, to obtain the necessary time for the onset of the causal treatment effect or is used as a bridge to transplantation Mortality of the patients varies according to the underlying cause and presence of risk factors (e.g., age, complications or comorbid diseases). The onset of the COVID-19 pandemic has led to a significant increase in the need for ECMO. The quality of life of patients after ECMO is significantly reduced, but most patients do not experience permanent disability | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a ECMO | |
| 650 | 4 | |a corticosteroid | |
| 650 | 4 | |a long-term outcome | |
| 650 | 4 | |a long-term results | |
| 700 | 1 | |a Šimek, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Jakubec, Petr |e verfasserin |4 aut | |
| 700 | 1 | |a Pobeha, Pavol |e verfasserin |4 aut | |
| 700 | 1 | |a Mizera, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Vykopal, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Kiml, Jakub |e verfasserin |4 aut | |
| 700 | 1 | |a Sova, Milan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Casopis lekaru ceskych |d 1948 |g 161(2023), 7-8 vom: 01., Seite 321-324 |w (DE-627)NLM000001805 |x 0008-7335 |7 nnns |
| 773 | 1 | 8 | |g volume:161 |g year:2023 |g number:7-8 |g day:01 |g pages:321-324 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 161 |j 2023 |e 7-8 |b 01 |h 321-324 | ||